New psoriasis treatments based upon a deeper understanding of the pathogenesis of psoriasis vulgaris and psoriatic arthritis: A personal appraisal of their use in practice

被引:8
作者
Callen, JP [1 ]
机构
[1] Univ Louisville, Sch Med, Div Dermatol, Louisville, KY 40202 USA
关键词
D O I
10.1067/S0190-9622(03)01149-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:351 / 356
页数:6
相关论文
共 19 条
[11]   A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis [J].
Krueger, GG ;
Papp, KA ;
Stough, DB ;
Loven, KH ;
Gulliver, WP ;
Ellis, CN .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (06) :821-833
[12]   New developments in the treatment of psoriasis [J].
Lebwohl, M .
ARCHIVES OF DERMATOLOGY, 2002, 138 (05) :686-688
[13]   Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept [J].
Lee, JH ;
Slifman, NR ;
Gershon, SK ;
Edwards, ET ;
Schwieterman, WD ;
Siegel, JN ;
Wise, RP ;
Brown, SL ;
Udall, JN ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (10) :2565-2570
[14]   Psoriasis treatment 2003 at the new millennium: Position paper on behalf of the authors [J].
Menter, MA ;
Krueger, GC ;
Feldman, SR ;
Weinstein, GD .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :S39-S43
[15]  
Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO
[16]  
2-W
[17]   Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study [J].
Paul, CF ;
Ho, VC ;
McGeown, C ;
Christophers, E ;
Schmidtmann, B ;
Guillaume, JC ;
Lamarque, V ;
Dubertret, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) :211-216
[18]   Drug-induced systemic lupus erythematosus associated with etanercept therapy [J].
Shakoor, N ;
Michalska, M ;
Harris, CA ;
Block, JA .
LANCET, 2002, 359 (9306) :579-580
[19]   Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor α receptor IgG1-Fc fusion complex therapy [J].
Smith, KJ ;
Skelton, HG .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (06) :953-956